News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,063 Results
Type
Article (117)
Company Profile (2)
Press Release (943)
Section
Business (167)
Career Advice (13)
Deals (19)
Drug Development (96)
Employer Resources (1)
FDA (5)
Job Trends (24)
News (299)
Policy (25)
Tag
Academia (15)
Allergies (1)
Alliances (56)
Alzheimer's disease (4)
Approvals (3)
Artificial intelligence (3)
Best Places to Work (15)
Biotechnology (2)
Breast cancer (1)
Cancer (7)
Career advice (10)
Career pathing (1)
Cell therapy (1)
Clinical research (77)
Collaboration (5)
COVID-19 (3)
C-suite (1)
Data (17)
Diagnostics (17)
Drug discovery (1)
Earnings (44)
Employer branding (1)
Employer resources (1)
Events (230)
FDA (6)
Funding (4)
Gene editing (1)
Gene therapy (3)
GLP-1 (1)
Government (4)
Healthcare (31)
Huntington's disease (1)
Infectious disease (4)
Interviews (2)
IPO (6)
Job creations (5)
Job search strategy (6)
Layoffs (1)
Leadership (1)
Legal (6)
Liver cancer (2)
Manufacturing (1)
Medical device (9)
Medtech (9)
Mergers & acquisitions (15)
Neurodegenerative disease (2)
Neuroscience (12)
NextGen: Class of 2026 (9)
Non-profit (19)
Opinion (1)
Parkinson's disease (3)
Patents (1)
People (56)
Phase 1 (11)
Phase 2 (35)
Phase 3 (42)
Pipeline (7)
Postmarket research (3)
Preclinical (9)
Press Release (3)
Psychedelics (1)
Radiopharmaceuticals (1)
Rare diseases (3)
Real estate (3)
Regulatory (19)
Research institute (15)
Resumes & cover letters (4)
RNA editing (1)
Schizophrenia (1)
Series A (1)
Startups (6)
Vaccines (5)
Venture capital (1)
Date
Last 7 days (3)
Last 30 days (5)
Last 365 days (51)
2026 (6)
2025 (53)
2024 (128)
2023 (88)
2022 (75)
2021 (146)
2020 (83)
2019 (101)
2018 (77)
2017 (52)
2016 (57)
2015 (76)
2014 (33)
2013 (17)
2012 (20)
2011 (20)
2010 (4)
Location
Africa (4)
Arkansas (1)
Asia (52)
Australia (9)
California (13)
Canada (5)
China (3)
Colorado (1)
Connecticut (1)
Europe (92)
Florida (2)
Illinois (3)
Indiana (1)
Massachusetts (16)
Minnesota (1)
Nevada (1)
New Jersey (6)
New York (5)
North Carolina (3)
Northern California (5)
Ohio (1)
Oregon (1)
Pennsylvania (8)
South America (2)
Southern California (4)
Tennessee (2)
Texas (2)
United States (64)
Utah (1)
1,063 Results for "delve bio.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Presentations at Association for Molecular Pathology 2025 Annual Meeting Spotlight Clinical Impact of Delve Bio’s Metagenomic Sequencing Test for Improving CNS Diagnosis
November 17, 2025
·
3 min read
Press Releases
New Data Show Early Use of Delve Bio’s Metagenomic Testing Can Reduce Need for Conventional Tests and Overall Length of Stay for Patients with Meningitis/Encephalitis
October 21, 2025
·
5 min read
Press Releases
Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect
December 4, 2024
·
3 min read
Press Releases
New Data Show Delve Bio’s Metagenomic Testing Delivers Broader, Deeper Pathogen Identification Compared to Traditional Testing
June 23, 2025
·
4 min read
Press Releases
New Data Show Delve Bio’s Metagenomic Platform Accurately Identifies Viruses and Their Subtypes With a Single Test
May 7, 2025
·
3 min read
Press Releases
Delve Bio to Present on Metagenomic Next Generation Sequencing (mNGS) at the American Academy of Neurology 2025 Annual Meeting
April 7, 2025
·
3 min read
Business
Delve Bio presents study showing utility of metagenomic next generation sequencing (mNGS) in diagnosing neurological infections
Delve Bio in collaboration with the University of California, San Francisco (UCSF), today announced data on the use of mNGS for the diagnosis of infectious causes of meningitis and/or encephalitis in real-world clinical settings.
April 17, 2024
·
4 min read
Genetown
Delve Bio Announces Clinical Data on the Use of Metagenomic Next-Generation Sequencing (mNGS) to Identify Pathogens Causing Central Nervous System Infections
Delve Bio in collaboration with the University of California, San Francisco (UCSF), today announced data from a study highlighting the utility and diagnostic yield of mNGS testing in cases of infectious meningitis, encephalitis, and/or myelitis among both adults and children at the American Society of Microbiology Microbe conference in Atlanta.
June 17, 2024
·
4 min read
Business
Delve Bio Appoints Jim Stuart as Chief Commercial Officer
Delve Bio, a pioneer in metagenomic next-generation sequencing for infectious diseases, announced the appointment of Jim Stuart as chief commercial officer and Jay Wohlgemuth, M.D., to the board of directors.
August 28, 2023
·
3 min read
Press Releases
Delve Bio Announces Partnership with Broad Clinical Labs for Metagenomic Next Generation Sequencing (mNGS)
October 9, 2024
·
3 min read
1 of 107
Next
